Quick Answer
Enveric Biosciences, Inc. reported Common Stock Shares Outstanding of 1.06 million shares for the year ending 2025.
- Enveric Biosciences, Inc. showed an increase of +1,778.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2010 to 2025), Enveric Biosciences, Inc.'s Common Stock Shares Outstanding has declined by 83.7%.
- Historical annual values: Fiscal year 2025: 1.06 million shares | Fiscal year 2024: 56,501 shares | Fiscal year 2023: 182,625 shares | Fiscal year 2022: 2.08 million shares | Fiscal year 2021: 651,921 shares | Fiscal year 2020: 10.10 million shares | Fiscal year 2019: 5.31 million shares | Fiscal year 2018: 1.69 million shares | Fiscal year 2017: 18.16 million shares | Fiscal year 2016: 13.89 million shares | Fiscal year 2014: 15.41 million shares | Fiscal year 2013: 12.14 million shares | Fiscal year 2012: 12.14 million shares | Fiscal year 2011: 12.14 million shares | Fiscal year 2010: 6.50 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: